Chest Mobility, Cough Strength, Muscle Strength, Physical Activity and Quality of Life in Parkinson’s Patients who have had COVID-19

GÜLSAH BARGI0 sites32 target enrollmentMay 25, 2023

Overview

No summary available.

Registry

who.int

Start Date

May 25, 2023

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

GÜLSAH BARGI

•Inclusion criteria for Parkinson's patients with COVID\-19;
•Being diagnosed with COVID\-19 at least 12 weeks ago and recovered,
•Being over 18 years old,
•Volunteering to participate in the research,
•Being diagnosed with Parkinson's disease
•Comorbid conditions (such as hypertension, diabetes) are under control
•Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
•Having the ability to ambulate and walk independently
•Being in stage 1 \- 4 according to the Modified Hoehn\-Yahr Scale
•Inclusion criteria for Parkinson's patients without COVID\-19;

•Exclusion criteria for Parkinson's patients with and without COVID\-19;
•Sudden drug or dose change during the study period
•A history of any acute/chronic orthopedic, cardiovascular, pulmonary, psychiatric or neuromuscular disease that may prevent measurements from being made.
•Having had myocardial infarction and pulmonary embolism in the last 30 days,
•Having a history of additional neurological (stroke, head trauma, peripheral nerve diseases, brain and spinal cord tumors, etc.) diseases other than Parkinson's disease
•Having severe vision loss or vestibular dysfunction
•Patients with blood pressure values above 140/90 and below 90/50 in blood pressure measurements made before the study, with arrhythmia on ECG, with a history of shortness of breath and/or palpitation